1. Home
  2. KE vs ABVX Comparison

KE vs ABVX Comparison

Compare KE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KE
  • ABVX
  • Stock Information
  • Founded
  • KE 1961
  • ABVX 2013
  • Country
  • KE United States
  • ABVX France
  • Employees
  • KE N/A
  • ABVX N/A
  • Industry
  • KE Electrical Products
  • ABVX
  • Sector
  • KE Technology
  • ABVX
  • Exchange
  • KE Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • KE 451.8M
  • ABVX 511.3M
  • IPO Year
  • KE N/A
  • ABVX N/A
  • Fundamental
  • Price
  • KE $18.85
  • ABVX $5.97
  • Analyst Decision
  • KE Buy
  • ABVX Buy
  • Analyst Count
  • KE 5
  • ABVX 4
  • Target Price
  • KE $22.20
  • ABVX $31.50
  • AVG Volume (30 Days)
  • KE 218.1K
  • ABVX 320.0K
  • Earning Date
  • KE 08-12-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • KE N/A
  • ABVX N/A
  • EPS Growth
  • KE N/A
  • ABVX N/A
  • EPS
  • KE 0.71
  • ABVX N/A
  • Revenue
  • KE $1,536,413,000.00
  • ABVX $11,444,012.00
  • Revenue This Year
  • KE N/A
  • ABVX $284.20
  • Revenue Next Year
  • KE N/A
  • ABVX N/A
  • P/E Ratio
  • KE $26.51
  • ABVX N/A
  • Revenue Growth
  • KE N/A
  • ABVX 128.98
  • 52 Week Low
  • KE $12.41
  • ABVX $4.77
  • 52 Week High
  • KE $24.45
  • ABVX $14.22
  • Technical
  • Relative Strength Index (RSI)
  • KE 57.97
  • ABVX 38.44
  • Support Level
  • KE $18.46
  • ABVX $5.75
  • Resistance Level
  • KE $19.59
  • ABVX $8.57
  • Average True Range (ATR)
  • KE 0.59
  • ABVX 0.55
  • MACD
  • KE -0.08
  • ABVX -0.17
  • Stochastic Oscillator
  • KE 55.59
  • ABVX 7.69

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: